Pharma/Biotech - Page 1 | TalkMarkets


All Posts > Content under Pharma/Biotech
1 to 16 of 4405 Posts
1 2 3 ... 276
Bulls And Bears Of The Week: Apple, Amazon, Biogen, Bitcoin, Tesla And More
Article By: Benzinga
Saturday, June 12, 2021 7:43 PM EDT
The S&P 500 did manage to eke out a new record high last week, but overall, Wall Street seemed to be in wait and see mode, with speculation that the reopening cycle may have already peaked.
Biotech Movers During ASCO Week
Article By: Rod Raynovich
Saturday, June 12, 2021 7:17 PM EDT
The biotech sector performed well in a good ASCO week. And many biotech stocks were movers this week as a bullish sentiment took hold sparked by the Biogen Aduhelm approval.
Week In Review: Shanghai CARsgen To Raise $400 Million In Hong Kong IPO
Article By: ChinaBio® Today
Saturday, June 12, 2021 12:44 PM EDT
Shanghai CARsgen Therapeutics is staging an IPO on the Hong Kong Exchange that could raise $400 million to support development of the company's CAR-T portfolio. The shares are scheduled to begin trading on June 18.
In this article: VRNA, ABBV, HCM, BGNE, 1801.HK, 1672.HK, 6855.HK
Pfizer Vs. Novavax: Which Vaccine Stock Is A Better Buy?
Article By: StockNews
Saturday, June 12, 2021 5:00 AM EDT
Vaccine stocks are still worthy of close analysis in spite of the fact that the coronavirus pandemic is gradually reaching its end.
In this article: PFE, NVAX
E The New Defiance "Psychedelic" ETF Is New But Not Groundbreaking
Article By: Lorimer Wilson
Friday, June 11, 2021 12:44 PM EDT
The supposedly first "psychedelic" drug stocks ETF was launched in the U.S. on May 27th. but it is not a true psychedelic drug stocks ETF nor is it the world's first psychedelic ETF.
In this article: HPSYF, PSY
Paratek Pharma - Trending Stock
Article By: Jim Van Meerten
Thursday, June 10, 2021 3:01 PM EDT
Revenue expected to grow 270.10% this year and another 16.20% next year. Earnings estimated to increase 92.00% this year and an additional 61.10% next year.
In this article: PRTK
Clover Health Downgraded To Underperform From Neutral At BofA
Article By: The Fly
Thursday, June 10, 2021 7:26 AM EDT
BofA analyst Kevin Fischbeck downgraded Clover Health Investments to Underperform from Neutral with an unchanged price target of $10.
In this article: CLOV Also: ALHC
3 Top Pharma Stocks To Buy This Month
Article By: StockNews
Wednesday, June 9, 2021 10:00 AM EDT
In 2020, pharmaceutical stocks came to the forefront as healthcare companies were searching for treatments for COVID-19.
In this article: BMY, JNJ, NVO Also: XPH
U.S. Approves Biogen's Alzheimer's Drug
Article By: Admiral Markets
Tuesday, June 8, 2021 9:00 AM EDT
During yesterday's session, the US pharmaceutical company based in Massachusetts, Biogen, experienced a strong rebound in the stock market after the FDA approved the use of its Alzheimer's drug known as Aduhelm.
In this article: BIIB
From Short Squeezes To Silver
Article By: David Pinsen
Tuesday, June 8, 2021 5:44 AM EDT
Updates on our two recent heavily-shorted top names; a shift to silver. 
In this article: AG, SLV, AMC, FLGT Also: PSLV
E Market Briefing For Tuesday, Jun. 8
Article By: Gene Inger
Tuesday, June 8, 2021 3:54 AM EDT
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first.
In this article: AAPL Also: SRNE, AMGN, BIIB, AMRN, LPTH
Can The Small Cap Index And The Transportation Sector Hold Key Support?
Article By: Michele Schneider
Sunday, June 6, 2021 5:33 AM EDT
For the small-cap Russell 2000 (IWM), $226.69 is an important level to hold as it shows the index can sustain itself over its main consolidation range dating back to early April.
In this article: IWM Also: LIT, IBB, QQQ, DBA, DIA, GLD, IYT, KRE, SMH, SPY, TLT, UGA, VBK, XOP, XRT, MJ
Opening Day: Payment Startup DLocal Raises $618M In IPO
Article By: The Fly
Saturday, June 5, 2021 7:42 PM EDT
Payment startup dLocal raised $617.65M in its initial public offering, the latest payment company to come public this year. Paymentus (PAY) and Flywire (FLYW​​​​​​​) both started trading last month, with Marqeta also set to go public soon.
In this article: DLO Also: PAY, VERA, FLGC, GLBE, DBGI, SMWB, EJH, FLYW
Week In Review: Zai Lab Enters $338 Million Agreement To In-License KRAS Inhibitor
Article By: ChinaBio® Today
Saturday, June 5, 2021 1:59 PM EDT
Shanghai's Zai Lab in-licensed Greater China rights to adagrasib, a KRASG12C inhibitor, from Mirati of San Diego in a $338 million agreement. Mirati will receive a $65 million upfront payment and up to $273 million in milestones, plus royalties.
In this article: LLY, AMGN, MRTX, ZLAB, 1801.HK, LYRA, 1877.HK
3 Dividend-Paying Pharmaceutical Stocks To Buy This Summer
Article By: StockNews
Saturday, June 5, 2021 7:00 AM EDT
The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic.
In this article: LLY, PFE, ABBV Also: IHE, PJP, MYOV
5 Stocks With Solid Track Records At Attractive Prices
Article By: Zacks Investment Research
Saturday, June 5, 2021 5:00 AM EDT
You could become rich, but there’s an equal chance that you’ll lose whatever you have.
In this article: TGH, AOSL, HBIO, LGIH, ARCB
1 to 16 of 4405 Posts
1 2 3 ... 276